Human HPSE2 gene transfer ameliorates bladder pathophysiology in a mutant mouse model of urofacial syndrome (2023)
Attributed to:
Preclinical gene therapy for genetic urinary bladder disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.07.03.547034
Publication URI: http://dx.doi.org/10.1101/2023.07.03.547034
Type: Preprint